Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Analysis of Suffix Use for Biosimilar Product Identification in Postmarketing Adverse Event Reporting.
Journal: Clinical pharmacology and therapeutics
Published: April 14, 2026
Correction: An Evaluation of Duplicate Adverse Event Reports Characteristics in the Food and Drug Administration Adverse Event Reporting System.
Journal: Drug safety
Published: July 25, 2025
An Evaluation of Duplicate Adverse Event Reports Characteristics in the Food and Drug Administration Adverse Event Reporting System.
Journal: Drug safety
Published: May 08, 2025
The Food and Drug Administration's (FDA's) Drug Safety Surveillance During the COVID-19 Pandemic.
Journal: Drug safety
Published: November 06, 2022
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 20, 2021
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.
Journal: The lancet. HIV
Published: October 31, 2019
Showing 1-6 of 6
Last Updated: 09/26/2026